Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer

Luis F Flores1, David L Marks1, Renzo E Vera1

  • 1Division of Oncology Research.

JCI Insight
|June 10, 2025
PubMed

Insights

Oncogenic mutant KRAS shrinks cancer cell nuclei by regulating Emerin (EMD). Depleting EMD increases nuclear size and reduces poorly differentiated pancreatic cancer, revealing a novel mechanism in PDAC carcinogenesis.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Nuclear shape and size alterations are hallmarks of cancer, historically used for diagnosis and staging.
  • The underlying mechanisms and biological significance of aberrant nuclear phenotypes in cancer remain largely unknown.

Purpose of the Study:

  • To investigate the mechanisms and biological significance of nuclear size changes in pancreatic ductal adenocarcinoma (PDAC).
  • To identify key molecular players regulating nuclear size in PDAC driven by oncogenic KRAS mutations.

Main Methods:

  • Utilized a PDAC model to study the effects of mutant KRAS on nuclear size.
  • Performed transcriptomic and protein expression analysis to identify differentially expressed genes.
  • Investigated the role of nuclear lamina protein Emerin (EMD) downstream of KRAS.
  • Analyzed human PDAC samples for EMD expression and nuclear size correlation.
  • Conducted in vivo genetic depletion of EMD in a PDAC model.

Main Results:

  • Oncogenic mutant KRAS was found to reduce nuclear size in PDAC cells.
  • Mutant KRAS expression altered the levels of nuclear envelope-associated genes, with Emerin (EMD) identified as a key mediator of nuclear size reduction.
  • Increased EMD expression in human PDAC samples correlated with reduced nuclear size.
  • In vivo EMD depletion in a KRAS-driven PDAC model led to increased nuclear size and a decreased incidence of poorly differentiated tumors.

Conclusions:

  • Identified a novel mechanism where mutant KRAS-driven Emerin (EMD) expression reduces nuclear size in pancreatic cancer.
  • Demonstrated that EMD plays a significant role in regulating nuclear size and differentiation status in PDAC.
  • These findings provide new insights into the molecular basis of nuclear morphology changes and their impact on PDAC carcinogenesis.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.3K